PCBP1 and PCBP2 both bind heavily oxidized RNA but cause opposing outcomes, suppressing or increasing apoptosis under oxidative conditions.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
21 08 2020
Historique:
received: 15 11 2019
revised: 06 07 2020
pubmed: 11 7 2020
medline: 20 1 2021
entrez: 11 7 2020
Statut: ppublish

Résumé

PCBP1, a member of the poly(C)-binding protein (PCBP) family, has the capability of binding heavily oxidized RNA and therefore participates in the cellular response to oxidative conditions, helping to induce apoptosis. There are four other members of this family, PCBP2, PCBP3, PCBP4, and hnRNPK, but it is not known whether they play similar roles. To learn more, we first tested their affinity for an RNA strand carrying two 8-oxoguanine (8-oxoG) residues at sites located in close proximity to each other, representative of a heavily oxidized strand or RNA with one 8-oxoG or none. Among them, only PCBP2 exhibited highly selective binding to RNA carrying two 8-oxoG residues similar to that observed with PCBP1. In contrast, PCBP3, PCBP4, and hnRNPK bound RNA with or without 8-oxoG modifications and exhibited slightly increased binding to the former. Mutations in conserved RNA-binding domains of PCBP2 disrupted the specific interaction with heavily oxidized RNA. We next tested PCBP2 activity in cells. Compared with WT HeLa S3 cells, PCBP2-KO cells established by gene editing exhibited increased apoptosis with increased caspase-3 activity and PARP1 cleavage under oxidative conditions, which were suppressed by the expression of WT PCBP2 but not one of the mutants lacking binding activity. In contrast, PCBP1-KO cells exhibited reduced apoptosis with much less caspase-3 activity and PARP cleavage than WT cells. Our results indicate that PCBP2 as well as PCBP1 bind heavily oxidized RNA; however, the former may counteract PCBP1 to suppress apoptosis under oxidative conditions.

Identifiants

pubmed: 32647012
pii: S0021-9258(17)50083-6
doi: 10.1074/jbc.RA119.011870
pmc: PMC7443489
pii:
doi:

Substances chimiques

DNA-Binding Proteins 0
Heterogeneous-Nuclear Ribonucleoprotein K 0
PCBP1 protein, human 0
PCBP2 protein, human 0
RNA-Binding Proteins 0
HNRNPK protein, human 146410-60-8
8-hydroxyguanine 5614-64-2
Guanine 5Z93L87A1R
RNA 63231-63-0
Poly(ADP-ribose) Polymerases EC 2.4.2.30
CASP3 protein, human EC 3.4.22.-
Caspase 3 EC 3.4.22.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12247-12261

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2020 Ishii et al.

Déclaration de conflit d'intérêts

Conflict of interest—The authors declare that they have no conflicts of interest with the contents of this article.

Références

Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):66-71
pubmed: 17190801
Pathol Res Pract. 2016 Aug;212(8):717-25
pubmed: 27461833
Biochem Biophys Res Commun. 2009 Mar 13;380(3):431-6
pubmed: 19284986
J Cell Physiol. 2018 Jan;234(1):33-41
pubmed: 30132844
J Biol Chem. 2016 Aug 12;291(33):17303-18
pubmed: 27302059
J Clin Invest. 2017 May 1;127(5):1786-1797
pubmed: 28375153
J Neurosci. 1999 Mar 15;19(6):1959-64
pubmed: 10066249
Neurochem Res. 2016 Sep;41(9):2401-14
pubmed: 27209304
Free Radic Biol Med. 2017 Jun;107:151-158
pubmed: 27833032
Mol Cell Biol. 2015 Nov 02;36(2):304-19
pubmed: 26527618
EMBO J. 1995 Sep 1;14(17):4357-64
pubmed: 7556077
Nat Rev Mol Cell Biol. 2007 Sep;8(9):722-8
pubmed: 17700625
Oncol Rep. 2014 May;31(5):2413-21
pubmed: 24627148
Nat Rev Cancer. 2002 Apr;2(4):277-88
pubmed: 12001989
Mol Cell Biol. 2003 Jun;23(11):3774-87
pubmed: 12748281
Int J Biochem Cell Biol. 2007;39(1):44-84
pubmed: 16978905
Curr Opin Cell Biol. 1999 Jun;11(3):363-71
pubmed: 10395553
Int J Biochem Cell Biol. 2016 Apr;73:127-136
pubmed: 26880484
Biol Chem. 2005 Apr;386(4):333-7
pubmed: 15899695
RNA. 1997 Aug;3(8):882-92
pubmed: 9257647
Free Radic Biol Med. 2015 Feb;79:109-16
pubmed: 25486179
Nat Rev Mol Cell Biol. 2008 Jan;9(1):47-59
pubmed: 18097445
Virology. 2008 Sep 1;378(2):243-53
pubmed: 18656221
Genomics. 2000 Aug 1;67(3):301-16
pubmed: 10936052
J Exp Clin Cancer Res. 2018 Aug 7;37(1):187
pubmed: 30086790
J Biol Chem. 1998 Aug 28;273(35):22648-56
pubmed: 9712894
Nucleic Acids Res. 2016 Nov 16;44(20):9902-9917
pubmed: 27387282
Eur J Biochem. 1995 Jun 1;230(2):447-53
pubmed: 7607214
DNA Repair (Amst). 2007 Jun 1;6(6):841-51
pubmed: 17374514
Oncogene. 2002 Dec 16;21(58):8895-904
pubmed: 12483507
Proc Natl Acad Sci U S A. 2018 Apr 17;115(16):4218-4222
pubmed: 29610342
DNA Repair (Amst). 2019 Sep;81:102666
pubmed: 31326364
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11115-20
pubmed: 8855318
J Virol. 1997 Aug;71(8):6243-6
pubmed: 9223526
Nucleic Acids Res. 2016 Jul 8;44(12):5491-503
pubmed: 27257056
Cell Death Differ. 2003 Aug;10(8):889-98
pubmed: 12867996
Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):6715-6720
pubmed: 29891675
Mitochondrion. 2007 Dec;7(6):367-73
pubmed: 17855174

Auteurs

Takashi Ishii (T)

Department of Biochemistry, Fukuoka Dental College, Fukuoka, Japan; Oral Medicine Research Center, Fukuoka Dental College, Fukuoka, Japan.

Tatsuhiro Igawa (T)

Frontier Research Center, Fukuoka Dental College, Fukuoka, Japan.

Hiroshi Hayakawa (H)

Department of Biochemistry, Fukuoka Dental College, Fukuoka, Japan.

Tsugumi Fujita (T)

Department of Biochemistry, Fukuoka Dental College, Fukuoka, Japan.

Mutsuo Sekiguchi (M)

Frontier Research Center, Fukuoka Dental College, Fukuoka, Japan.

Yusaku Nakabeppu (Y)

Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan. Electronic address: yusaku@bioreg.kyushu-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH